Emerging roles of kisspeptin/galanin in age-related metabolic disease
Copyright © 2021 Elsevier B.V. All rights reserved..
Age is a major risk factor for developing metabolic diseases such as obesity and diabetes. There is an unprecedented rise in obesity and type 2 diabetes in recent decades. A convincing majority of brain-gut peptides are associated with a higher risk to develop metabolic disorders, and may contribute to the pathophysiology of age-related metabolic diseases. Accumulating basic studies revealed an intriguing role of kisspeptin and galanin involved in the amelioration of insulin resistance in different ways. In patients suffered from obesity and diabetes a significant, sex-related changes in the plasma kisspeptin and galanin levels occurred. Kisspeptin is anorexigenic to prevent obesity, its level is negatively correlative with obesity and insulin resistance. While galanin is appetitive to stimulate food intake and body weight, its level is positively correlative with obesity, HOMA-IR and glucose/triglyceride concentration. In turn, kisspeptin and galanin also distinctly increase glucose uptake and utilization as well as energy expenditure. This article reviews recent evidence dealing with the role of kisspeptin and galanin in the pathophysiology of age-related metabolic diseases. It should be therefore taken into account that the targeted modulation of those peptidergic signaling may be potentially helpful in the future treatment of age-related metabolic diseases.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:199 |
|---|---|
| Enthalten in: |
Mechanisms of ageing and development - 199(2021) vom: 15. Okt., Seite 111571 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fang, Penghua [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
88813-36-9 |
|---|
| Anmerkungen: |
Date Completed 17.02.2022 Date Revised 17.02.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.mad.2021.111571 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM330591738 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM330591738 | ||
| 003 | DE-627 | ||
| 005 | 20231225211620.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.mad.2021.111571 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1101.xml |
| 035 | |a (DE-627)NLM330591738 | ||
| 035 | |a (NLM)34517021 | ||
| 035 | |a (PII)S0047-6374(21)00143-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fang, Penghua |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Emerging roles of kisspeptin/galanin in age-related metabolic disease |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.02.2022 | ||
| 500 | |a Date Revised 17.02.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Elsevier B.V. All rights reserved. | ||
| 520 | |a Age is a major risk factor for developing metabolic diseases such as obesity and diabetes. There is an unprecedented rise in obesity and type 2 diabetes in recent decades. A convincing majority of brain-gut peptides are associated with a higher risk to develop metabolic disorders, and may contribute to the pathophysiology of age-related metabolic diseases. Accumulating basic studies revealed an intriguing role of kisspeptin and galanin involved in the amelioration of insulin resistance in different ways. In patients suffered from obesity and diabetes a significant, sex-related changes in the plasma kisspeptin and galanin levels occurred. Kisspeptin is anorexigenic to prevent obesity, its level is negatively correlative with obesity and insulin resistance. While galanin is appetitive to stimulate food intake and body weight, its level is positively correlative with obesity, HOMA-IR and glucose/triglyceride concentration. In turn, kisspeptin and galanin also distinctly increase glucose uptake and utilization as well as energy expenditure. This article reviews recent evidence dealing with the role of kisspeptin and galanin in the pathophysiology of age-related metabolic diseases. It should be therefore taken into account that the targeted modulation of those peptidergic signaling may be potentially helpful in the future treatment of age-related metabolic diseases | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Age | |
| 650 | 4 | |a Galanin | |
| 650 | 4 | |a Kisspeptin | |
| 650 | 4 | |a Metabolic diseases | |
| 650 | 7 | |a Kisspeptins |2 NLM | |
| 650 | 7 | |a Galanin |2 NLM | |
| 650 | 7 | |a 88813-36-9 |2 NLM | |
| 700 | 1 | |a She, Yuqing |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Juan |e verfasserin |4 aut | |
| 700 | 1 | |a Yan, Jing |e verfasserin |4 aut | |
| 700 | 1 | |a Yu, Xizhong |e verfasserin |4 aut | |
| 700 | 1 | |a Jin, Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Wei, Qingbo |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Zhenwen |e verfasserin |4 aut | |
| 700 | 1 | |a Shang, Wenbin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Mechanisms of ageing and development |d 1973 |g 199(2021) vom: 15. Okt., Seite 111571 |w (DE-627)NLM000007528 |x 1872-6216 |7 nnns |
| 773 | 1 | 8 | |g volume:199 |g year:2021 |g day:15 |g month:10 |g pages:111571 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.mad.2021.111571 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 199 |j 2021 |b 15 |c 10 |h 111571 | ||